Skip to content

Dry Cupping Therapy in Knee Osteoarthritis

CompletedNot applicableNCT04331158
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Introduction: Knee osteoarthritis (KOA) is the biggest cause of pain and disability worldwide. As a non-pharmacological approach, ventosatherapia has been used to control pain, improve function and quality of life. However, there is a lack of high-quality scientific evidence regarding its effects on this condition. Objective: To evaluate the effects of dry cupping on pain, function and quality of life in women with KOA. Methods: This is a randomized, blinded placebo-controlled protocol. 62 women diagnosed with KOA will be recruited, based on the clinical criteria of the American College of Rheumatology, who will be randomly divided into two groups (31 per group): dry cupping and dry cupping sham.

Study details

Official title
The Effects of Dry Cupping on Pain, Function and Quality of Life of Women With Knee Osteoarthritis: Protocol for a Placebo-controlled Randomized Trial
Interventions
  • Other: Dry cupping therapy
Sponsor
Universidade Federal do Rio Grande do Norte
Start date
2023-02-01
Primary completion
2023-09-01
Sex
Female
Age range
from 50 Years to 75 Years
Results posted
No results posted in this snapshot
Countries
Brazil
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosed with KOA based on ACR clinical criteria; * Knee pain intensity between 3 and 8, according to the Numerical Pain Scale (END); * BMI less than 35 kg / m2. Exclusion Criteria: * Having undergone physical therapy treatment for the knee in the 3 months prior to the project; * Be engaged in\> 45 minutes / week in accumulated physical activity of at least moderate intensity; * To have been submitted to the application and / or intervention with the wind therapy previously. * Have used corticosteroid infiltration in the knee in the last 6 months; * Present any medical restrictions that make it impossible for them to participate in the proposed assessments and interventions (cardiorespiratory, neurological and / or musculoskeletal changes); * Presenting a diagnosis of fibromyalgia, rheumatoid arthritis or some systemic inflammatory arthritis; * Presenting a ligament or meniscal injury diagnosed clinically or with a positive result in the Apley tests or anterior / posterior drawer; * Have had previous surgery on the ankle, knee or hip; * Present a clinical diagnosis of some dementia or inability to answer the questionnaires related to the study; * Present any contraindications for the use of ventosatherapia (skin lesion in the region where it will be applied, cancer, kidney failure, liver and heart failure, pacemaker, pregnancy); * Having uncontrolled diabetes and hypertension; * Have a trip scheduled for the two months following inclusion in the survey.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04331158